Groundbreaking trial aims to protect moms and babies from mpox
Prevention
Ongoing
This study is testing the safety and immune response of the MVA-BN mpox vaccine in pregnant and recently delivered women in the Democratic Republic of the Congo, where mpox is a risk. It will enroll 359 women to receive two vaccine doses either during pregnancy or right after giv…
Phase: PHASE3 • Sponsor: Jean-Pierre Van geertruyden • Aim: Prevention
Last updated Mar 30, 2026 14:28 UTC